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In This IssueStem Cells at the Single-Cell Level
ETZRODT ET AL., 546
Shroeder and colleagues review current state-of-the-art approaches used to query stem cell fate at
the single-cell level, including advances in lineage tracing, time-lapse imaging, and molecular
profiling. They also offer their perspective on advantages and drawbacks of available approaches,
key technical limitations, considerations for data interpretation, and future innovation.
Sensing BMP in the Hair Follicle Niche
GENANDER ET AL., 619
Selective ablation of BMP signaling in stem and progenitor cells within the hair follicle combined
with in-depth genomic profiling reveals cell-type-specific roles in the regulation of proliferation
and lineage specification.
Conserved Regenerative Mechanisms for
Heart Repair
AGUIRRE ET AL., 589
Zebrafish have an inherent capacity to regenerate injured hearts, whereas adult mammals have lost
this capacity. Izpisua Belmonte and colleagues now identify mechanisms underlying cardiac regeneration in zebrafish that are conserved yet inactive in
mammals, and experimental reactivation of these effectors is sufficient to regenerated infarcted myocardium in mammals.
Pol II Puts a Pause on Reprogramming
LUI ET AL., 574
The transition of Pol II from a paused to a productive elongation stage is a rate-limiting step for inducing pluripotency genes in reprogramming. This
transition is promoted by the recruitment of active P-TEFb to pluripotency gene promoters, which is simultaneously coordinated by BRD4 and KLF4.
(Top image.)
Hepatocytes Contribute to the Progenitor Pool
TARLOW ET AL., 605
Ductal metaplasia in bothmouse and human adult hepatocytes is reversible, suggesting amechanism for how hepatocytes can escape injury, expand,
and redifferentiate into functional hepatocytes after damage subsides.
A Stem-Cell-Based Approach Suppresses Epilepsy Symptoms
CUNNINGHAM ET AL., 559
In a mouse model of temporal lobe epilepsy, Cunningham et al. use optogenetic approaches to analyze hESC-derived GABAergic interneurons
transplanted into the hippocampus. Engrafted cells suppressed spontaneous seizure activity as well as seizure-associated cognitive deficits,
aggressiveness, and hyperactivity. Preview by Goldberg and Coulter.
Is SCNT Better than iPSCs for Reprogramming?
JOHANNESSON ET AL., 634
Johannesson et al. compare human somatic cells reprogrammed to pluripotency via SCNT and iPSCs. They find similar gene expression and DNA
expression and comparable levels of genomic aberrations such as coding mutations and imprinted gene expression defects, suggesting that neither
reprogramming method is superior in this regard. Preview by Colman and Burley.
CRISPR/Cas9-based Gene Targeting in Human HSCs
MANDAL ET AL., 643
Genome editing has the potential to revolutionize cell-based gene therapy. In this study, Cowan,
Rossi, and colleagues developed approaches for using CRISPR/Cas9 in human CD34+ HSPCs
that yielded high on-target, with minimal off-target, mutagenesis. These results indicate that
CRISPR/Cas9 could broadly enable gene- and cell-based therapies of blood. Preview by
Calero-Garcia and Gaspar.
Stem Cell Therapies for Parkinson’s Disease
Take a Step Closer to the Clinic
GREALISH ET AL., 653 AND BARKER, 539
Preclinical evidence shows that hESC-derived dopamine neurons are functionally equivalent to
those derived from fetal tissue, supporting continued development of hESC-derived cells as a
clinical approach for the treatment of Parkinson’s disease. In a related Forum, Roger Barker dis-
cusses the promise for treating Parkinson’s disease by transplantation with stem-cell-derived neu-
rons, but cautions that this step should only be undertaken when all the key issues have been
adequately resolved. (Bottom image.)Cell Stem Cell 15, November 6, 2014 ª2014 Elsevier Inc. xiii
